---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-022162"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:29:21.523260+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences closes $60M rights offering at $10/unit, oversubscribed 138%

## Summary
- Raised $60M gross from 6M units; each unit = 1 share + 2 warrants to buy 0.5 share at $11.
- Subscriptions exceeded $83M from 800+ accounts, including Executive Chairman Robert Duggan.
- Post-offering shares outstanding: 61,228,332; warrants for up to ~6M additional shares issued.
- Proceeds to fund CellFX nsPFA products: Percutaneous Electrode, Cardiac Clamp, 360° Catheter.
- Warrants exercisable immediately for 5 years; redeemable if stock exceeds $16.50 or $22 for 20 days.

## SEC filing metadata
- accession: 0001437749-24-022162
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774924022162/0001437749-24-022162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774924022162/plse20240702_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-022162
- JSON: https://secwatch.observer/filing/0001437749-24-022162.json
- Plain text: https://secwatch.observer/filing/0001437749-24-022162.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.